Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatocellular Carcinoma Non-resectable”

694 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 694 results

Testing effectiveness (Phase 2)Looking for participantsNCT05844046
What this trial is testing

Sequential or Up-front Triple Treatment With Durvalumab, Tremelimumab and Bevacizumab for Non-resectable Hepatocellular Carcinoma (HCC) Patients

Who this might be right for
Hepatocellular Carcinoma
Enrico De Toni 83
Large-scale testing (Phase 3)Study completedNCT01229839
What this trial is testing

Chemoembolization With or Without Mixing the Chemotherapy With Lipiodol for Unresectable HCC

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 668
Not applicableStudy completedNCT04670445
What this trial is testing

Improving Patient and Caregiver Understanding of Risks and Benefits of Immunotherapy for Advanced Cancer

Who this might be right for
Stage IV MelanomaAdvanced Lung CancerStage IV Non-Small Cell Lung Cancer+19 more
Massachusetts General Hospital 199
Early research (Phase 1)Study completedNCT00004604
What this trial is testing

Biological Therapy in Treating Patients With Metastatic Cancer

Who this might be right for
Breast CancerColorectal CancerExtrahepatic Bile Duct Cancer+9 more
Duke University 24
Not applicableStudy completedNCT00683631
What this trial is testing

TheraSphere HUD For Treatment of Unresectable Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Carcinoma
University of Louisville 183
Early research (Phase 1)Study completedNCT02870010
What this trial is testing

Chemoembolization of Non-resectable Non-metastatic Hepatocellular Carcinoma Using Embolization Microspheres

Who this might be right for
Localized Non-Resectable Adult Hepatocellular Carcinoma
Centre Hospitalier Universitaire Dijon 21
Not applicableLooking for participantsNCT05248581
What this trial is testing

Living Donor Liver Transplant for Unresectable Colorectal Liver Metastases

Who this might be right for
Colorectal Cancer Metastatic
University of Rochester 25
Not applicableStudy completedNCT00950144
What this trial is testing

Studying Pain and Symptom Distress in Patients With Advanced Colon Cancer, Rectal Cancer, Pancreatic Cancer, or Liver Cancer

Who this might be right for
Colorectal CancerDepressionFatigue+3 more
City of Hope Medical Center 123
Not applicableLooking for participantsNCT07305428
What this trial is testing

Downstaging Unresectable Hepatocellular Carcinoma to Resectable Disease With Combined Immunotherapy and Stereotactic Beamed Radiotherapy: a Pilot Study

Who this might be right for
HCC - Hepatocellular CarcinomaUnresectable Hepatocellular Carcinoma
The University of Hong Kong 30
Testing effectiveness (Phase 2)Study completedNCT01352728
What this trial is testing

Hepatocellular Carcinoma (HCC) Transarterial Chemoembolisation (TACE) +Axitinib

Who this might be right for
Hepatocellular Carcinoma
Chinese University of Hong Kong 50
Testing effectiveness (Phase 2)UnknownNCT06040177
What this trial is testing

Efficacy and Safety of SBRT Combined With Cardonilizumab and Lenvastinib in the Treatment of Unresectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombus

Who this might be right for
Hepatocellular Carcinoma Non-resectablePortal Vein Tumor ThrombusImmune Checkpoint Inhibitors
First Affiliated Hospital of Guangxi Medical University 30
Testing effectiveness (Phase 2)UnknownNCT05214339
What this trial is testing

A Trial of Hepatic Arterial Infusion Combined With Bevacizumab and Sintilimab for Unresectable A-staged Hepatocellular Carcinoma in BCLC Classification (D-TRIPLET)

Who this might be right for
Unresectable Hepatocellular CarcinomaHepatocellular Carcinoma by BCLC Stage
Sun Yat-sen University 30
Not applicableUnknownNCT02847767
What this trial is testing

Dynamic Contrast Enhanced HCC SABR Liver Study

Who this might be right for
Carcinoma, Hepatocellular
British Columbia Cancer Agency 20
Not applicableUnknownNCT04111029
What this trial is testing

Liquid Biopsy in Hepatocellular Carcinoma

Who this might be right for
Hepatic Carcinoma Malignant Primary Non-Resectable
Post Graduate Institute of Medical Education and Research, Chandigarh 30
Not applicableUnknownNCT04967495
What this trial is testing

TACE Plus Multikinase Inhibitor and I-125 Seeds Brachytherapy for HCC With Branch PVTT

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Second Affiliated Hospital of Guangzhou Medical University 171
Large-scale testing (Phase 3)Study completedNCT00617981
What this trial is testing

Phase 3 Study of ThermoDox With Radiofrequency Ablation (RFA) in Treatment of Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Carcinoma
Imunon 701
Testing effectiveness (Phase 2)Looking for participantsNCT06911255
What this trial is testing

Safety and Efficacy of Tremelimumab+Durvalumab(MEDI4736)+TACE in Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma (HCC)Unresectable Hepatocellular Carcinoma
Yoon Jun Kim 24
Not applicableLooking for participantsNCT05994859
What this trial is testing

SIRT for Potentially Resectable HCC

Who this might be right for
Hepatocellular Carcinoma
Second Affiliated Hospital of Guangzhou Medical University 35
Large-scale testing (Phase 3)Looking for participantsNCT05608213
What this trial is testing

Lenvatinib Plus I-125 Seed Brachytherapy vs. Lenvatinib for TACE-refractory HCC

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Second Affiliated Hospital of Guangzhou Medical University 187
Testing effectiveness (Phase 2)Looking for participantsNCT05269381
What this trial is testing

Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors

Who this might be right for
Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Anatomic Stage IIIB Breast Cancer AJCC v8+98 more
Mayo Clinic 138
Next Page